Health TidingsJanux discontinues JANX008 after Phase 1a results over efficacy Janux discontinues JANX008 after Phase 1a results over efficacy Read Post »
Health TidingsGilead Completes $7.8 Billion Acquisition of Arcellx, Gains Full Control of... Gilead Completes $7.8 Billion Acquisition of Arcellx, Gains Full Control of... Read Post »
Health TidingsTerns Advances TERN-701 with FDA Breakthrough Therapy Designation in CML Terns Advances TERN-701 with FDA Breakthrough Therapy Designation in CML Read Post »
Health TidingsFDA Seeks to Withdraw TAVNEOS After Identifying Efficacy Gaps FDA Seeks to Withdraw TAVNEOS After Identifying Efficacy Gaps Read Post »
Health TidingsJohnson & Johnson Secures FDA Priority Review for IMAAVY® in wAIHA Johnson & Johnson Secures FDA Priority Review for IMAAVY® in wAIHA Read Post »
Health TidingsOncolytics Biotech Aligns with FDA on Pivotal Trial Design for Pelareorep i... Oncolytics Biotech Aligns with FDA on Pivotal Trial Design for Pelareorep i... Read Post »
Health TidingsGSK moves efimosfermin forward with dual US FDA Breakthrough and EMA PRIME ... GSK moves efimosfermin forward with dual US FDA Breakthrough and EMA PRIME ... Read Post »
Health TidingsJazz Marks FDA Acceptance, Priority Review Milestone for Zanidatamab Jazz Marks FDA Acceptance, Priority Review Milestone for Zanidatamab Read Post »
Health TidingsAbbVie Steps Beyond Infusion with SC SKYRIZI Filing in Crohn’s Disease AbbVie Steps Beyond Infusion with SC SKYRIZI Filing in Crohn’s Disease Read Post »
Health Tidings Mergers & AcquisitionsBioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition BioMarin Bolsters Its Rare Disease Portfolio Through Amicus Acquisition Read Post »
Health TidingsGSK stands firm on Jemperli as AnaptysBio seeks to reclaim rights GSK stands firm on Jemperli as AnaptysBio seeks to reclaim rights Read Post »
GenericsAlembic Secures USFDA Approval for Fingolimod capsules for MS Alembic Secures USFDA Approval for Fingolimod capsules for MS Read Post »
Health Tidings Mergers & AcquisitionsSun Pharma Acquires Organon in $11.75 Billion Deal Sun Pharma Acquires Organon in $11.75 Billion Deal Read Post »
Health TidingsCompass Pathways gains priority voucher, speeds COMP360 review Compass Pathways gains priority voucher, speeds COMP360 review Read Post »
Health TidingsNovartis Pulls Back Pluvicto as CHMP Raises Red Flag Novartis Pulls Back Pluvicto as CHMP Raises Red Flag Read Post »
Health TidingsGrace Therapeutics Hits CRL Wall in GTx-104 Approval Bid Grace Therapeutics Hits CRL Wall in GTx-104 Approval Bid Read Post »
Health TidingsAstellas Amends Mirabegron Deal with MSN, Secures $75 Million Upfront Astellas Amends Mirabegron Deal with MSN, Secures $75 Million Upfront Read Post »
Health Tidings Mergers & AcquisitionsAbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE AbbVie Receives FDA Complete Response Letter for TrenibotulinumtoxinE Read Post »
Health TidingsConnect Biopharma Stays the Course as Rademikibart Meets Interim Benchmarks Connect Biopharma Stays the Course as Rademikibart Meets Interim Benchmarks Read Post »
ManufacturingMHRA Recalls Napralief Painkiller Over Missing Safety Information MHRA Recalls Napralief Painkiller Over Missing Safety Information Read Post »
GenericsCipla Expands U.S. Presence with Approval of Generic Albuterol Inhaler Cipla Expands U.S. Presence with Approval of Generic Albuterol Inhaler Read Post »
CRO Medical DevicesLabcorp Expands Newly Approved PD-L1 Assay, Enabling Rapid Identification o... Labcorp Expands Newly Approved PD-L1 Assay, Enabling Rapid Identification o... Read Post »
Health Tidings Mergers & AcquisitionsAmneal Bets Big on Biosimilars with Kashiv Acquisition Amneal Bets Big on Biosimilars with Kashiv Acquisition Read Post »
Health TidingsModerna Steps Up the Guard with Phase 3 Trial for Bird Flu Vaccine Moderna Steps Up the Guard with Phase 3 Trial for Bird Flu Vaccine Read Post »
Health TidingsFDA Extends the Runway for Sarclisa SC Approval Decision FDA Extends the Runway for Sarclisa SC Approval Decision Read Post »
Health TidingsInhibrx Reports Positive CRC Data for Ozekibart Inhibrx Reports Positive CRC Data for Ozekibart Read Post »
Health Tidings¥700 Million GHIT Funding Targets Innovative Treatments for Falciparum and... ¥700 Million GHIT Funding Targets Innovative Treatments for Falciparum and... Read Post »
Health Tidings Mergers & AcquisitionsCompass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Compass Pathways Builds the Path to Nationwide COMP360 Delivery with Osmind Read Post »
Health TidingsRegulatory Update Expected for LYTENAVA™ in May Regulatory Update Expected for LYTENAVA™ in May Read Post »
Health TidingsImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer ImmunityBio Launches ANKTIVA in Saudi Arabia for Bladder and Lung Cancer Read Post »
Health TidingsOtsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Otsuka Unit Taiho Halts Phase 3 STAR-121 Trial After Futility Analysis Read Post »
Health TidingsLantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Lantern Pharma Plans FDA Meeting on HARMONIC Trial Amendments for LP-300 in... Read Post »
Health TidingsRoche Pushes Gazyva Across the Regulatory Finish Line in SLE Roche Pushes Gazyva Across the Regulatory Finish Line in SLE Read Post »
Health TidingsFDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... FDA Priority Review Granted to KEYTRUDA Combinations in MIBC Based on Phase... Read Post »
Health TidingsDose Mix-Up Triggers Recall of Ramipril Capsules in UK Dose Mix-Up Triggers Recall of Ramipril Capsules in UK Read Post »
Health Tidings Mergers & AcquisitionsBiogen Takes Full Control of Felzartamab from TJ Biopharma Biogen Takes Full Control of Felzartamab from TJ Biopharma Read Post »
ManufacturingAskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... AskBio Scales Up Production of Ametefgene Parvec to Support Ongoing Phase I... Read Post »
Health Tidings Mergers & AcquisitionsEli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Eli Lilly to Acquire Kelonia Therapeutics for Up to $7 Billion, Advancing I... Read Post »
GenericsANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge ANI Pharmaceuticals Rolls Out Generic Pimozide, Gains 180-Day Edge Read Post »
Health TidingsPasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Pasithea Therapeutics Secures FDA Rare Pediatric Disease Designation for NF... Read Post »
GenericsAlembic, Aurobindo Secure USFDA ANDA Approvals Alembic, Aurobindo Secure USFDA ANDA Approvals Read Post »
Health Tidings Regulatory & Health PolicyFederal Order Expands Access and Research for Psychedelic Therapies Federal Order Expands Access and Research for Psychedelic Therapies Read Post »
Health TidingsVYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP VYVGART Opens New Doors Across MG Subtypes and Steps Earlier Into CIDP Read Post »
Health Tidings Mergers & AcquisitionsUCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move UCB Seeks to Rebuild Brain Balance with $1.15B Neurona Move Read Post »
Health Tidings Mergers & AcquisitionsGilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Gilead Sciences, Inc. Clears Final Hurdles, Locks in Arcellx, Inc. Deal Read Post »
Health Tidings Mergers & AcquisitionsVir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Vir Biotechnology Closes Astellas Deal to Advance VIR-5500 in Prostate Canc... Read Post »
Health TidingsMolgramostim Review Timeline Extended, FDA Seeks More Time on Savara’s BL... Molgramostim Review Timeline Extended, FDA Seeks More Time on Savara’s BL... Read Post »
Health TidingsFDA to Puts Peptides Back Under Scientific Review FDA to Puts Peptides Back Under Scientific Review Read Post »
Health TidingsImmutep Win Orphan Drug Designation for Eftilagimod Alfa in STC Immutep Win Orphan Drug Designation for Eftilagimod Alfa in STC Read Post »
Health TidingsBIZENGRI Steps into the Breach: A Targeted Push Against Rare Bile Duct Canc... BIZENGRI Steps into the Breach: A Targeted Push Against Rare Bile Duct Canc... Read Post »
